First Light Asset Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,073,110
Closed -$3.35M 79
2023
Q3
$3.35M Sell
1,073,110
-784,456
-42% -$3.15M 0.32% 40
2023
Q2
$8.53M Buy
1,857,566
+493,344
+36% +$2.27M 0.67% 37
2023
Q1
$6.75M Sell
1,364,222
-1,121
-0.1% -$5.52K 0.61% 35
2022
Q4
$7.45M Buy
1,365,343
+2,800
+0.2% +$17.2K 0.69% 34
2022
Q3
$8.86M Buy
1,362,543
+43,054
+3% +$240K 0.9% 34
2022
Q2
$6.24M Sell
1,319,489
-1,917
-0.1% -$9.44K 0.73% 35
2022
Q1
$9.24M Buy
1,321,406
+89,129
+7% +$609K 0.81% 34
2021
Q4
$12.6M Buy
1,232,277
+237,607
+24% +$2.55M 0.9% 33
2021
Q3
$12.1M Buy
+994,670
New +$15M 0.8% 37

Other funds holding MXCT

First Light Asset Management's MXCT Position: Q4 2023 in Review

First Light Asset Management sold out of MaxCyte (MXCT) in Q4 2023, closing a stake of 1,073,110 shares — an estimated $3.35M sold.

First Light Asset Management first reported a position in MXCT in Q3 2021 and held it in 9 quarters. The position peaked at $12.6M in Q4 2021. 120 funds tracked by Wall St. Rank hold MXCT as of Q4 2023.

  • First Light Asset Management reported no remaining MaxCyte position as of Q4 2023 after selling out during the quarter.
  • First Light Asset Management sold 1,073,110 MaxCyte shares in Q4 2023, an estimated $3.35M.
  • First Light Asset Management first reported a position in MaxCyte in Q3 2021 and held it in 9 quarters.
  • First Light Asset Management's MaxCyte position peaked at $12.6M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q4 2023.

Based on First Light Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.